2015
DOI: 10.1111/pme.12565
|View full text |Cite
|
Sign up to set email alerts
|

The Effect of Hydromorphone Therapy on Psychophysical Measurements of the Descending Inhibitory Pain Systems in Patients with Chronic Radicular Pain

Abstract: These results suggest that the descending inhibitory pain modulation, as manifested in humans by CPM and OA, is unlikely to be mediated by hydromorphone therapy.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
37
0

Year Published

2015
2015
2021
2021

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 24 publications
(37 citation statements)
references
References 31 publications
0
37
0
Order By: Relevance
“…This is further supported by studies showing that the administration of ketamine (a N‐methyl‐ d ‐aspartate (NMDA) antagonist) influences CPM, but not offset analgesia (Niesters, Dahan, et al, ) suggesting that CPM is NMDA‐dependent, and offset analgesia is NMDA‐independent. Administration of hydromorphone (an opioid) does not have an effect on CPM or offset analgesia in pain patients (Suzan, Treister, Pud, Haddad, & Eisenberg, ). Administration of remifentanil (an opioid agonist) and naloxone (an opioid antagonist) to healthy subjects does not alter offset analgesia (Martucci, Eisenach, Tong, & Coghill, ), suggesting that offset analgesia is opioid‐independent whereas administration of morphine impairs the CPM in healthy subjects (Martini et al, ), which suggests that CPM is opioid‐dependent.…”
Section: Discussionmentioning
confidence: 99%
“…This is further supported by studies showing that the administration of ketamine (a N‐methyl‐ d ‐aspartate (NMDA) antagonist) influences CPM, but not offset analgesia (Niesters, Dahan, et al, ) suggesting that CPM is NMDA‐dependent, and offset analgesia is NMDA‐independent. Administration of hydromorphone (an opioid) does not have an effect on CPM or offset analgesia in pain patients (Suzan, Treister, Pud, Haddad, & Eisenberg, ). Administration of remifentanil (an opioid agonist) and naloxone (an opioid antagonist) to healthy subjects does not alter offset analgesia (Martucci, Eisenach, Tong, & Coghill, ), suggesting that offset analgesia is opioid‐independent whereas administration of morphine impairs the CPM in healthy subjects (Martini et al, ), which suggests that CPM is opioid‐dependent.…”
Section: Discussionmentioning
confidence: 99%
“…The complementary mechanisms behind OA and its pain attenuation still remain unclear, but impaired OA‐effects have been observed in different groups of chronic pain patients. The chronic neuropathic pain patients showed reduced OA‐effect (Niesters et al., ; Suzan et al., ), which could imply that the peripheral pathologies reduce OA and that peripheral mechanisms are involved in OA. In addition, the reduced OA‐effect has also been observed in patients with central sensitization, such as fibromyalgia (Julien et al., ; Oudejans et al., ).…”
Section: Discussionmentioning
confidence: 99%
“…Ketamine [76], tapentadol [77], opioid agonists [78], [79], and an opioid antagonist [78] have not shown any modulatory effect.…”
Section: Offset Analgesiamentioning
confidence: 96%